Neurotransmitters such as dopamine, serotonin, and gamma-aminobutyric acid (GABA) play pivotal roles in addiction. Dopamine, often linked to the brain's reward system, is excessively released during substance use, reinforcing the behavior and creating a cycle of dependency. Serotonin dysregulation can lead to mood disturbances, increasing susceptibility to addiction. GABA, a neurotransmitter responsible for calming the brain, becomes imbalanced, leading to heightened anxiety and withdrawal symptoms. These disruptions alter neural pathways, making it challenging to break free from addiction. Recovery often focuses on restoring neurotransmitter balance through pharmacological interventions and behavioral therapies. Understanding the role of neurotransmitters sheds light on addiction's complexity, emphasizing the importance of tailored treatment strategies that address these biochemical changes for sustainable recovery.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Sexualizing anxiety and anxiolytic sex: Misattribution of arousal
Sam Vaknin, Commonwealth Institute of Advanced Professional Studies, United Kingdom
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Denise Duffie, TeDDs on Chapel, Centre for Recovery, Canada